CC
Colrain Capital Portfolio holdings
AUM
$130M
This Quarter Return
+8.38%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$982M
AUM Growth
+$982M
(+3%)
Cap. Flow
-$44.3M
Cap. Flow
% of AUM
-4.51%
Top 10 Holdings %
Top 10 Hldgs %
38.96%
Holding
91
New
5
Increased
17
Reduced
53
Closed
11
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$9.39M |
| 2 |
International Paper
IP
|
$7.1M |
| 3 |
PepsiCo
PEP
|
$5.87M |
| 4 |
Capital One
COF
|
$5.85M |
| 5 |
Devon Energy
DVN
|
$4.24M |
Top Sells
| 1 |
Valero Energy
VLO
|
$7M |
| 2 |
GE Aerospace
GE
|
$6.2M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$6.08M |
| 4 |
Iron Mountain
IRM
|
$4.93M |
| 5 |
Leidos
LDOS
|
$3.85M |
Sector Composition
| 1 | Healthcare | 22.77% |
| 2 | Technology | 15.09% |
| 3 | Financials | 14.8% |
| 4 | Industrials | 12.74% |
| 5 | Communication Services | 12.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
American International
AIG
$44.9B
| $15.9M | 1.61% |
256,950
-25,050
| -9% | -$1.55M |
|
27
Walmart
WMT
$781B
| $11.9M | 1.2% |
193,500
-2,500
| -1% | -$153K |
|
|
28
Devon Energy
DVN
$23.1B
| $10.3M | 1.04% |
321,350
+132,350
| +70% | +$4.24M |
|
|
29
Valero Energy
VLO
$47.9B
| $9.65M | 0.98% |
136,500
-99,000
| -42% | -$7M |
|
|
30
Leidos
LDOS
$23.2B
| $9.06M | 0.92% |
160,982
-68,518
| -30% | -$3.85M |
|
31
Occidental Petroleum
OXY
$47.3B
| $9M | 0.91% |
133,050
-34,600
| -21% | -$2.34M |
|
|
GG
32
DELISTED
Goldcorp Inc
GG
| $8.13M | 0.82% |
703,150
-5,350
| -0.8% | -$61.8K |
|
33
Saic
SAIC
$5.54B
| $7.46M | 0.76% |
162,968
-3,032
| -2% | -$139K |
|
34
Gilead Sciences
GILD
$140B
| $6.97M | 0.71% |
68,900
+7,550
| +12% | +$764K |
|
35
AbbVie
ABBV
$374B
| $6.84M | 0.69% |
115,500
-16,000
| -12% | -$948K |
|
|
APC
36
DELISTED
Anadarko Petroleum
APC
| $6.76M | 0.68% |
139,050
-1,900
| -1% | -$92.3K |
|
37
Chubb
CB
$110B
| $6.72M | 0.68% |
57,500
-2,500
| -4% | -$292K |
|
38
Merck
MRK
$214B
| $6.51M | 0.66% |
123,300
-1,700
| -1% | -$89.8K |
|
39
Morgan Stanley
MS
$238B
| $6.49M | 0.66% |
204,000
-3,500
| -2% | -$111K |
|
40
JPMorgan Chase
JPM
$824B
| $6.23M | 0.63% |
94,300
-2,700
| -3% | -$178K |
|
41
MetLife
MET
$53.6B
| $6.03M | 0.61% |
125,000
-21,000
| -14% | -$1.01M |
|
|
42
PepsiCo
PEP
$206B
| $5.87M | 0.59% |
+58,700
| New | +$5.87M |
|
43
Abbott
ABT
$229B
| $4.9M | 0.5% |
109,000
-11,000
| -9% | -$494K |
|
44
Berkshire Hathaway Class B
BRK.B
$1.08T
| $4.16M | 0.42% |
31,500
+1,500
| +5% | +$198K |
|
45
Bunge Global
BG
$16.3B
| $4.05M | 0.41% |
59,300
+5,800
| +11% | +$396K |
|
|
46
Alphabet (Google) Class C
GOOG
$2.56T
| $3.98M | 0.4% |
5,244
-319
| -6% | -$242K |
|
47
Archer Daniels Midland
ADM
$29.8B
| $3.83M | 0.39% |
104,500
+49,000
| +88% | +$1.8M |
|
48
UnitedHealth
UNH
$280B
| $3.42M | 0.35% |
29,027
-15,873
| -35% | -$1.87M |
|
49
The Mosaic Company
MOS
$10.6B
| $3.23M | 0.33% |
117,000
+23,500
| +25% | +$648K |
|
50
Eaton
ETN
$134B
| $2.91M | 0.29% |
55,900
-15,800
| -22% | -$822K |
|